1. Home
  2. LION vs QURE Comparison

LION vs QURE Comparison

Compare LION & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

N/A

Current Price

$11.13

Market Cap

3.4B

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$23.38

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LION
QURE
Founded
1997
1998
Country
Canada
Netherlands
Employees
N/A
248
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.1B
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
LION
QURE
Price
$11.13
$23.38
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$11.89
★ $68.25
AVG Volume (30 Days)
★ 2.1M
1.9M
Earning Date
05-21-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.67
EPS
★ N/A
N/A
Revenue
★ $2,631,800,000.00
$13,107,000.00
Revenue This Year
N/A
$55.91
Revenue Next Year
$22.98
$356.42
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.88
$8.73
52 Week High
$16.70
$71.50

Technical Indicators

Market Signals
Indicator
LION
QURE
Relative Strength Index (RSI) 44.69 19.51
Support Level $10.92 $21.91
Resistance Level $11.74 $27.66
Average True Range (ATR) 0.43 2.13
MACD 0.05 -2.26
Stochastic Oscillator 49.22 10.03

Price Performance

Historical Comparison
LION
QURE

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: